Individualized Secondary Preventative Strategies in PAD: The Emerging Role of Factor Xa Anticoagulation

Individualized Secondary Preventative Strategies in PAD: The Emerging Role of Factor Xa Anticoagulation

On-Demand Webcast
FACULTY

Constantino Peña, MD
Medical Director of Vascular Imaging
Miami Cardiac & Vascular Institute 
Miami, Florida

Joshua Beckman, MD
Director, Section of Vascular Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

Fadi Saab, MD, FACC, FSCAI
Chief Operations Officer
Advanced Cardiac & Vascular Amputation Prevention Centers
Grand Rapids, Michigan

Michael Jaff, DO
President
Newton-Wellesley Hospital
Boston, Massachusetts

PROVIDER STATEMENT

 Provided by North American Center for Continuing Medical Education, LLC, an HMP Company.

For questions regarding this educational activity, please call (609) 371-1137 or email info@naccme.com.

INTENDED LEARNERS

This activity is designed for interventional radiologists, vascular surgeons, interventional cardiologists, interventional neuroradiologists, cardiothoracic surgeons, clinical cardiologists, clinical radiologists, neurologists, internists, nurses, and others involved in the treatment of cardiovascular disease.

LEARNING OBJECTIVES

After participating in this activity, participants should be better able to:

  • Recognize the downstream clinical and socioeconomic consequences of suboptimal secondary preventative practices in PAD
  • Evaluate the clinical trial data surrounding the efficacy and safety of factor Xa anticoagulation for the secondary prevention of MACE and MALE across PAD patient populations
  • Integrate the latest clinical data and guideline recommendations into comprehensive and individualized secondary preventative strategies for patients with PAD
CLAIMING CREDIT

To be eligible for credit, participants must complete the online activity, a post-test assessment, and the evaluation. Upon completing the activity, there will be instructions on how to print a certificate or other documentation of credit.

Release Date: March 15, 2019
Expiration Date: March 15, 2020
Estimated Time to Complete: 1 hour

There is no fee associated with this activity.

COMMERCIAL SUPPORT

NACCME would like to thank the following company who has supported the Individualized Secondary Preventative Strategies in PAD: The Emerging Role of Factor Xa Anticoagulation through an educational grant: Janssen Scientific Affairs, LLC.

CONTINUING EDUCATION

  In support of improving patient care, NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIANS

NACCME designates This on-demand activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING

This continuing nursing education activity awards 1.0 contact hours.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hours.

PHYSICIANS ASSISTANTS

NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 credit(s). PAs should only claim credit commensurate with the extent of their participation.

USE OF PROPRIETARY NAMES

This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.

UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES

This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of NACCME.

DISCLAIMERS

The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

Neither NACCME nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.

The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

NACCME, LLC  is an independent provider(s) of continuing medical education.  NACCME, LLC  has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

NACCME, LLC  assures that all educational materials are reviewed to ensure for the absence of commercial bias, fair balance, scientific objectivity, and levels of evidence. The educational activity will not be influenced by commercial organizations and will not conflict with any other scheduled educational activities.

According to the disclosure policy of  NACCME , faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of  NACCME  to initiate a mechanism to resolve the conflict. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

Clinical Reviewer 
Adam Geronemus, MD
Interventional Radiologist
Miami Cardiac and Vascular Institute
Miami, Florida

Planning Committee

In addition to the faculty listed below, NACCME planners and staff include Susie Seaman, NP; Susan Yarbrough, Imedex; and MaryEllen Fama, Caitlin Eastman, Jennifer Ilcyn, Donna Brophy, and Colleen Waters, NACCME.

Faculty

The faculty has reported the following:

Dr. Beckman: Consultant – Astra Zeneca, BMS, Boehringer Ingelheim, Merck, Sanofi; Grant/Research Support – Bayer, DSMB, Novartis

Dr. Geronemus: Speakers' Bureau – Bard, Gore, Merit, Penumbra, Sirtex

Dr. Jaff : Consultant – American Orthotics and Prosthetics Association, Micell, Philips, Silk Road Medical, Vactronix, Venarum, Volcano; Major Stock Shareholder – Embolitech, Gemini, Janacare, MC10, PQ Bypass, Primacea, Sano V, Vascular Therapies

Dr. Peña: Consultant – Boston Scientific, Cook Medical, CR Bard, Halyard Health, Prairie Research; Speakers’ Bureau – Brightwater Medical, Cagent Vascular

Dr. Saab: Consultant – BD Bard, Boston Scientific, Cardiovascular Systems Inc, Cardio Flow, Gore, Medtronic, Philips, Terumo Medical

Ms. Seaman: Scientific Advisor—Healthpoint BioTherapeutics, Mölnlycke Health Care; Speakers' Bureau—Mölnlycke Health Care

Susan Yarbrough, MaryEllen Fama, Caitlin Eastman, Jennifer Ilcyn, Donna Brophy, and Colleen Waters have disclosed no relevant financial relationships with any commercial interests.

ADA STATEMENT

North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

PRIVACY POLICY

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint providers. NACCME and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2019 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.